Antibiotic Stewardship and Sepsis: A Balancing Act
Recorded On: 12/19/2019
Description:
This webinar presents an overview of antibiotic stewardship and recent research regarding antibiotic treatments and sepsis care. Strategies to prevent antibiotic resistance and provide optimal care for sepsis patients are discussed. The CDC's latest guidance and new research on antibiotic stewardship is presented. Antibiotic stewardship program experience in hospital settings is shared.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Define antibiotic stewardship;
- Restate the role of de-escalation of antibiotics after sepsis treatment;
- Identify key challenges related to antibiotic stewardship in care of patients with sepsis;
- Summarize recent guidelines concerning antibiotic stewardship and sepsis;
- Describe how to implement an antibiotic stewardship program in a hospital setting.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by bioMérieux, 410 Medical, and BD.
George Sakoulas, MD
Infectious Diseases Clinician, Associate Professor
Sharp Memorial Hospital, University of California, San Diego School of Medicine
Dr. Sakoulas earned his medical degree from Harvard Medical School, Boston, Massachusetts, and completed his postgraduate training in internal medicine at Beth Israel Deaconess Medical Center in 1998. From 1998-1999 he served as chief medical resident in the Department of Medicine at Beth Israel Deaconess Medical Center. From 1999 to 2002, he was a fellow in infectious diseases at Beth Israel Deaconess Medical Center where he developed interests in Gram positive infections. He is an active infectious diseases clinician in the Sharp Healthcare System in San Diego. His academic affiliation is Associate Professor of Pediatrics at the University of California San Diego School of Medicine, Division of Host-Microbe Systems and Therapeutics where he is part of the Collaborative to Halt Antibiotic-Resistant Microbes (CHARM).
Sarah Kabbani, MD, MSc
Medical Officer
Centers for Disease Control and Prevention
Sarah Kabbani, MD, MSc, is an adult infectious disease physician in the Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention. Dr. Kabbani completed her internal medicine residency at Wayne State University in Michigan. After working as an academic hospitalist for two years at Beaumont Health System, she joined Emory University in 2011 for her post-doctoral infectious disease fellowship. During her fellowship, she completed a Master of Science in Clinical Research at Emory working with population surveillance data and was awarded an NIH T32 training grant in vaccinology. In 2016, Dr. Kabbani joined the Office of Antibiotic Stewardship where her areas of concentration include older adult and long term care antibiotic stewardship.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.25 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.